CASSS cultivates a global community
of industry, academic, and regulatory professionals to work together to resolve scientific challenges in the field of biopharmaceutical development and regulation.

Upcoming Events
-
Consultants' NetworkMarch 23, 2026 -
DC Discussion GroupApril 9, 2026 -
BioassaysApril 27 to 29, 2026 -
Virtual Summit on ManufacturingMay 7, 2026 -
Virtual Summit on BioconjugatesMay 28, 2026 -
The Netherlands Area Biotech Discussion GroupJune 4, 2026 -
CGTP SummitJune 8, 2026 -
Cell and Gene Therapy ProductsJune 9 to 11, 2026 -
CMC Strategy Forum EuropeJune 23 to 26, 2026 -
CMC Strategy Forum North AmericaJuly 28 to 29, 2026 -
CMC Strategy Forum Latin America Session IAugust 12, 2026 -
CMC Strategy Forum Latin America Session IIAugust 19, 2026 -
Mass SpectrometrySeptember 15 to 18, 2026 -
CE PharmSeptember 27 to 30, 2026 -
Cell and Gene Therapy Products EuropeOctober 20 to 22, 2026 -
CMC Strategy Forum JapanDecember 7 to 8, 2026 -
WCBPJanuary 26 to 28, 2027
Latest CASSS News
Member Month and Collaborations of 3
Feb 26, 2026
Throughout Member Month, we highlight who CASSS is and how we can help you and your career. Explore our Collaborations of 3.
Member Spotlight: Patrick McGeehan
Feb 23, 2026
Today’s spotlight shines on Patrick McGeehan, Senior Director, CMC Regulatory Affairs at AstraZeneca.

WCBP is one of those conferences where the conversations really matter. You’re in the room with people from industry and the FDA, talking openly about real CMC challenges—things like filing strategies, comparability, and how new technologies like AI might actually be used in practice. It feels much less like a conference full of slides, and more like thoughtful, technical discussions you can take back and apply to your work.
—Himani Singh Mengi, WCBP 2026